Integra Lifesciences Holdings (IART) Cash from Discontinued Operations (2014 - 2015)
Integra Lifesciences Holdings (IART) reported Cash from Discontinued Operations of 18937000.0 for Q2 2015, down 381.47% sequentially from 6728000.0 in Q1 2015.
Integra Lifesciences Holdings (IART) Cash from Discontinued Operations (2014 - 2015) Analysis & Trends
Integra Lifesciences Holdings (IART) has 2 years of Cash from Discontinued Operations data on file, last reported at 18937000.0 in Q2 2015.
- For the quarter ending Q2 2015, Cash from Discontinued Operations changed N/A year-over-year to 18937000.0; the trailing twelve-month figure through Mar 2016 stood at 18937000.0 (changed N/A YoY), and the FY2015 full-year result was 12209000.0, down 159.21% from the prior year.
- Cash from Discontinued Operations declined to 18937000.0 in Q2 2015, from 6728000.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 6728000.0 in Q1 2015 to a low of 18937000.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | - |
| 10 | Integra Lifesciences Holdings | 1.52 Bn | 1.26 Bn | 216.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | -18.94 Mn |
| Jun 30, 2015 | -18.94 Mn |
| Mar 31, 2015 | 6.73 Mn |
| Mar 31, 2015 | 6.73 Mn |
| Dec 31, 2014 | 2.86 Mn |
| Dec 31, 2014 | 2.86 Mn |